"Hypoxanthine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.
| Descriptor ID |
D019271
|
| MeSH Number(s) |
D03.633.100.759.758.399.475
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hypoxanthine".
Below are MeSH descriptors whose meaning is more specific than "Hypoxanthine".
This graph shows the total number of publications written about "Hypoxanthine" by people in this website by year, and whether "Hypoxanthine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypoxanthine" by people in Profiles.
-
Long Y, Sanchez-Espiridion B, Lin M, White L, Mishra L, Raju GS, Kopetz S, Eng C, Hildebrandt MAT, Chang DW, Ye Y, Liang D, Wu X. Global and targeted serum metabolic profiling of colorectal cancer progression. Cancer. 2017 Oct 15; 123(20):4066-4074.
-
Walcourt A, Loyevsky M, Lovejoy DB, Gordeuk VR, Richardson DR. Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites. Int J Biochem Cell Biol. 2004 Mar; 36(3):401-7.
-
Ochieng J, Patrick DE, Utz ED, Trewyn RW. Inhibition of phorbol ester-mediated phenotypic changes in cultured cells by hypoxanthine. Carcinogenesis. 1987 Nov; 8(11):1629-33.